Adagio Medical Holdings Inc/$ADGM
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Adagio Medical Holdings Inc
Adagio Medical Holdings Inc is a medical device company focused on developing and commercializing products for the treatment of cardiac arrhythmias with its proprietary, catheter-based Ultra-Low Temperature Ablation (ULTA) technology. UTLA is designed to create large, durable lesions extending through the depth of both diseased and healthy cardiac tissue. The company is currently focused on the treatment of ventricular tachycardia (VT), a rapid, abnormal heart rhythm, or arrhythmia, that originates in the heart's lower chambers, or ventricles. The company has one reportable segment.
Ticker
$ADGM
Sector
Primary listing
Employees
41
Headquarters
Website
ADGM Metrics
BasicAdvanced
$16m
-
-$1.33
-
-
Price and volume
Market cap
$16m
52-week high
$2.58
52-week low
$0.70
Average daily volume
103k
Financial strength
Current ratio
1.849
Quick ratio
1.506
Long term debt to equity
416.838
Total debt to equity
420.769
Interest coverage (TTM)
-6.52%
Profitability
EBITDA (TTM)
-18.784
Management effectiveness
Return on assets (TTM)
-30.52%
Return on equity (TTM)
-268.88%
Valuation
Price to book
2.72
Price to tangible book (TTM)
-1.02
Price to free cash flow (TTM)
-0.802
Free cash flow yield (TTM)
-124.77%
Free cash flow per share (TTM)
-0.873
Growth
Earnings per share change (TTM)
-81.60%
ADGM News
AllArticlesVideos

Adagio Medical Reports First Quarter 2026 Results and Meaningful Clinical Progress
Business Wire·1 month ago

Adagio Medical Announces Positive Pivotal Results for vCLAS® Ventricular Ablation System
Business Wire·2 months ago

Adagio Medical Receives IDE Approval from the FDA to Investigate Next-Generation vCLAS® Ventricular Ablation System
Business Wire·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs